Association of Peritoneal Cytology with Other Prognostic Factors in Endometrial Cancer
Authors:
- 1 October 2022
- journal article
- research article
- Published by Medknow in Journal of Cytology
- Vol. 39 (4) , 155-158
Abstract
Purpose: It is still debatable whether surgical staging of endometrial cancer (EC) should include sampling of peritoneal cytology (PC) and for what purpose this should be done. The aim of our study was to determine the significance of peritoneal cytology in EC and its association with other histological and clinical parameters. Methods: This is a retrospective study that comprises of results from 357 patients with EC that were operated in our center in the previous nine years. Patients were divided into two groups: the first group with a positive and the second group with a negative PC. Results: Malignant cells were found in the peritoneal cytology of 23 patients (6.4%), while 334 patients (93.6%) had negative PC. There was no significant difference in patients' age between the two groups (p = 0.20). Peritoneal cytology was more prevalent in the non-endometrioid than the endometrioid subtype of EC (p = 0.00). There was a significant statistical difference (p = 0.00) in malignant PC in stages where cancer is confined to the uterus (International Federation of Gynecologists and Obstetricians (FIGO) stages I and II) compared with those where cancer has metastasized outside the uterus (stages III and IV). Most of the patients with malignant PC (69.6%) had high-grade disease (G3). Conclusion: Malignant peritoneal cytology is associated with other negative prognostic factors in endometrial cancer (histological grade, FIGO stage, and non-endometrioid histological subtypes). Based on these findings, we encourage sampling of peritoneal washing in all EC patients and consider it mandatory in patients with non-endometrioid subtype, high-grade histology, and in advanced FIGO stage.Keywords
This publication has 16 references indexed in Scilit:
- Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer DatabaseAmerican Journal of Obstetrics and Gynecology, 2018
- Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2018
- Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolGynecologic Oncology, 2017
- Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysisJapanese Journal of Clinical Oncology, 2016
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancerGynecologic Oncology, 2013
- Revised FIGO staging for carcinoma of the endometriumInternational Journal of Gynecology & Obstetrics, 2009
- Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosisBritish Journal of Cancer, 2004
- Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterusBritish Journal of Cancer, 2003
- The Significance of Peritoneal Cytology in Uterine Cervix and Endometrial CancerGynecologic Oncology, 1997